Uwe Rix

19PUBLICATIONS
98CO-AUTHORS
Molecular targetsCancer cell biologyGene and molecular therapyProteins and peptidesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jun 04, 2026
Targeting GSTZ1 Sensitizes KRASG12C-Mutant Lung Cancer Cells by Overcoming Glutathione and Glycolysis Pathway Rewiring.

|Dec 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in EML4-ALK-driven lung cancer by concurrent integrin and MET signaling.

Qianqian Hu, Lily L Remsing Rix, Bina Desai

|Nov 06, 2025
Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells.

Juhyeon Son, Lily L Remsing Rix, Bin Fang

|Oct 30, 2025
RAS-GTP Inhibition Overcomes Acquired Resistance to KRASG12C Inhibitors Mediated by Oncogenic and Wild-Type RAS Activation in Non-Small Cell Lung Cancer.

Hitendra S Solanki, Harshit Shah, Denis Imbody

|Sep 10, 2024
Cancer-associated fibroblasts confer ALK inhibitor resistance in EML4-ALK -driven lung cancer via concurrent integrin and MET signaling.

Qianqian Hu, Lily L Remsing Rix, Bina Desai

|May 24, 2023
Targeting BET Proteins Downregulates miR-33a To Promote Synergy with PIM Inhibitors in CMML.

Christopher T Letson, Maria E Balasis, Hannah Newman

Pageof 4

Frequent Collaborators

7 joint publications

John M Koomen

7 joint publications

Eric Haura

4 joint publications

Bina Desai

4 joint publications

Bin Fang